BeyondSpring names Min Qiu CEO in leadership transition effective July 1, 2026

BeyondSpring Inc.

BeyondSpring Inc.

BYSI

0.00
  • BeyondSpring set a management transition effective July 1, 2026, to focus on its confirmatory DUBLIN-4 Phase 3 program for Plinabulin in NSCLC.
  • Founder Lan Huang will remain chairman, shifting day-to-day focus to SEED Therapeutics, where she is co-founder, chairman, CEO.
  • Director Jiangwen (Jen) Majeti will become vice chairman; she has held senior roles at Amgen, Roche, BioDuro/PPD, Erasca.
  • Min Qiu will take over as CEO; he has led corporate development work for five years, previously served as board secretary at Guangyuyuan.
  • Na Li will become CFO; she has been CFO of Dalian Wanchunbulin Pharmaceutical since 2020, with two decades of finance leadership.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeyondSpring Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606040700PRIMZONEFULLFEED9731678) on June 04, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.